With costs soaring for clinical trials of new drugs, Ukraine could join India, Israel and Thailand as a major site for this fast growing industry

With costs soaring for clinical trials of new drugs, Ukraine could join India, Israel and Thailand as a major site for this fast growing industry, James Peyer, managing partner of American biotech company Apollo Ventures told a Ukraine House Davos health panel sponsored by TA Ventures. “There is a good opportunity for a country like Ukraine, which is very European, but not under the auspices of the European Medicines Agency.” Running a company dedicated to finding drugs to combat age-related diseases, he said: “Clinical trials could be done [in Ukraine] with the same level professionalism, with the same level of efficiency of the the US and Europe — but without the cost.”